Lave plasma ziconotid koncentrationer, metabolisme af ubikvitære peptidaser og relativt lav plasma protein binding (se afsnit 5. 2) gør imidlertid metabolisme- baserede interaktioner eller interaktioner af plasma protein forskydningstypen mellem ziconotid og andre lægemidler usandsynlig.
However, low plasma ziconotide concentrations, metabolism by ubiquitous peptidases and relatively low plasma protein binding (see section 5.2) make metabolic-based interactions or plasma protein displacement type interactions between ziconotide and other medicinal products unlikely.